The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis.
about
Current adjuvant treatment modalities for gastric cancer: From history to the futureNeo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectivesNeoadjuvant therapy for gastric cancer: current evidence and future directionsValue of screening endoscopy in evaluation of esophageal, gastric and colon cancersGastric cancer: prevention, risk factors and treatmentAdjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step ForwardGastric cancer arising from the remnant stomach after distal gastrectomy: a reviewGastric cáncer: Overview.PAK as a therapeutic target in gastric cancerLocal targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicinGastric intestinal metaplasia is associated with gastric dysplasia but is inversely correlated with esophageal dysplasiaImplications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base.Treatment of gastric adenocarcinoma may differ among hospital types in the United States, a report from theNational Cancer Data Base.Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.Genome-wide gene copy number and expression analysis of primary gastric tumors and gastric cancer cell linesMTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer.The prognostic value of lymph nodes dissection number on survival of patients with lymph node-negative gastric cancer.Biglycan enhances gastric cancer invasion by activating FAK signaling pathwayThe Antigastric Cancer Activity of San Leng Powder Extract Induces Apoptosis in Balb/C Bearing-SGC-7901 Mice.Recurrent gastric cancer metastasizing to the bone marrow: A case report of a rare presentationAdjuvant Chemotherapy with Docetaxel, Cisplatin, and Continuous-Infusion 5-Fluorouracil for Gastric Cancer: A Phase II Study.Adjuvant chemo-radiation for gastric adenocarcinoma: an institutional experience.Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.Does the retrieval of at least 15 lymph nodes confer an improved survival in patients with advanced gastric cancer?Trends in clinical features, postoperative outcomes, and long-term survival for gastric cancer: a Western experience with 1,278 patients over 30 years.Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS).MiRNA as potential biomarkers and therapeutic targets for gastric cancer.The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma.Flavonoids Isolated from Korea Citrus aurantium L. Induce G2/M Phase Arrest and Apoptosis in Human Gastric Cancer AGS CellsRacial and ethnic disparities in gastric cancer outcomes: more important than surgical technique?Treatment and outcomes of gastric cancer among United States-born and foreign-born Asians and Pacific Islanders.Benefit of Adjuvant Chemoradiotherapy for Gastric Adenocarcinoma: A SEER Population AnalysisIs retrieval of at least 15 lymph nodes sufficient recommendation in early gastric cancer?Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival.Effect of lymph node micrometastases on prognosis of gastric carcinoma.A population-based analysis of surgical and adjuvant therapy for resected gastric cancer: are patients receiving appropriate treatment following publication of the intergroup 0116 results?LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathway.SUVmax/THKmax as a biomarker for distinguishing advanced gastric carcinoma from primary gastric lymphomaClinical and prognostic association of transcription factor SOX4 in gastric cancer.
P2860
Q26748744-6F26FE58-6AF2-40ED-B79C-7E4EB927E273Q26774283-DB8BAE60-F23D-48C5-A6FD-6C8704854CDDQ26781043-8C9D9CEE-DF04-4F34-92BB-7997EF4387D7Q26781528-07AEB8B0-7B62-48CE-B0E9-23531CF9A721Q26828903-B8A27DE6-AC33-48B8-A040-AF61A6D8DF5DQ26858776-0C2E3825-6262-4965-AED6-F834791F8365Q27021280-35BE71E7-A940-4E7D-A541-07A21E16BF28Q27692548-8BF45523-4D31-42E3-8713-EA8621111E58Q28272877-39C1304D-DAB0-47DC-B7D3-C24B9AB4E87AQ28533299-2E33B0EA-B222-4646-9FED-11A0018F7D71Q30253061-C2178A75-B643-44AC-9A59-BDC0F659EA95Q30826217-CDAE57A1-1C12-4042-830A-F70762910D32Q31109443-16E70EEA-3E82-42A9-BE30-C998FC1FF692Q33374960-C49A2742-47EF-470F-84D2-0C4F9C6C268BQ33378937-FCAE9ED4-2F09-48FB-95CB-AB4C9008D446Q33534919-0FD95507-E4AB-44DE-9718-00A46904343FQ33579778-6F96263F-F12D-48EF-81B2-6D48A4C07A28Q33608236-6FCB267A-81FA-43A3-8ED8-ACE6328AC051Q33688404-EFACE65D-94AA-48B0-B09B-80A3A8D728EBQ33711200-8E15607E-1200-43B9-9919-73E6B34D1A20Q33877262-C097DB5B-6FE8-4425-9AE6-8C42C2C69BD1Q33912309-3FC8361A-4792-44A8-BDD0-6E79C7D01D07Q33922105-CAEB5AE1-E43E-4794-BE3F-B548F9C90B50Q33926592-BCDF4701-76E6-4B5C-AF5C-858F1615677FQ33927570-7E2B59DB-039F-47C6-8628-BE37D1D45CFCQ33965000-6920DEF6-2307-41D1-AD13-FEFEEF5DA108Q33978927-12317052-64A2-486F-BE98-A7FF36C3CF7FQ34036679-FFDB1637-D3E3-4F25-AFF8-4B910E3EC443Q34087033-EB274AEF-5AD5-4AC1-B2FD-1785E6B6CB16Q34109841-FBCE6B18-1E64-49CB-9E75-BEE92A09E781Q34137266-CDE93BBC-BABA-4527-B42C-A5049D705D09Q34192776-E629F9C5-E320-4973-9F68-CB0A1ACA51D6Q34229413-D919594F-973F-42A5-A7F5-676F8E1840D4Q34335754-BBBE0265-EDC7-4EE4-8400-C994798DEB9BQ34353211-2B8B05CB-4CE1-471F-9CAD-0B139B8582A1Q34382139-F2B701E7-508E-412A-9CFA-F0EE5657EC96Q34395969-A4682652-8C4A-4953-AF53-156D84396EC3Q34487171-7D24961A-3A25-4449-8127-24A05A99C781Q34506646-B61DF90A-634C-4CAB-9BBF-669C6FEFC696Q34534615-8F27CB46-BFE8-4ED3-AF65-8F6A539C7780
P2860
The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The National Cancer Data Base ...... different disease" hypothesis.
@ast
The National Cancer Data Base ...... different disease" hypothesis.
@en
type
label
The National Cancer Data Base ...... different disease" hypothesis.
@ast
The National Cancer Data Base ...... different disease" hypothesis.
@en
prefLabel
The National Cancer Data Base ...... different disease" hypothesis.
@ast
The National Cancer Data Base ...... different disease" hypothesis.
@en
P2093
P1433
P1476
The National Cancer Data Base ...... different disease" hypothesis.
@en
P2093
P304
P356
10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-S
P407
P577
2000-02-01T00:00:00Z